CHTCX
Price
$19.48
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
3.77B
FXAIX
Price
$264.80
Change
+$0.34 (+0.13%)
Updated
Jun 2 closing price
Net Assets
832.15B
Interact to see
Advertisement

CHTCX vs FXAIX

Header iconCHTCX vs FXAIX Comparison
Open Charts CHTCX vs FXAIXBanner chart's image
CHTCX vs FXAIX Comparison Chart in %
View a ticker or compare two or three
VS
CHTCX vs. FXAIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHTCX is a Hold and FXAIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 832B vs. CHTCX (3.77B). FXAIX pays higher dividends than CHTCX: FXAIX (1.03) vs CHTCX (0.00). CHTCX was incepted earlier than FXAIX: CHTCX (29 years) vs FXAIX (15 years). CHTCX (1.76) is less costly to investors than FXAIX (0.01). CHTCX is a more actively managed with annual turnover of: 36.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than CHTCX: FXAIX (0) vs CHTCX (1000). FXAIX annual gain was more profitable for investors over the last year : 29.57 vs. CHTCX (11.38). FXAIX return over 5 years is better than : 94.64 vs. CHTCX (5.93).
CHTCXFXAIXCHTCX / FXAIX
Total Expense Ratio1.760.0111,733%
Annual Report Gross Expense Ratio1.760.0111,733%
Fund Existence29 years15 years-
Gain YTD6.10011.56253%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.77B832B0%
Annual Yield % from dividends0.001.03-
Returns for 1 year11.3829.5738%
Returns for 3 years31.8084.7338%
Returns for 5 years5.9394.646%
Returns for 10 years13.15301.464%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RRX213.9811.89
+5.88%
Regal Rexnord Corp
LGCL2.100.05
+2.34%
Lucas GC Limited
ORIS0.56-0.01
-1.26%
Oriental Rise Holdings Ltd
PRTH6.42-0.15
-2.28%
Priority Technology Holdings
MLYS28.85-2.26
-7.26%
Mineralys Therapeutics